The number of brain MR scans obtained in the clinical and research setting increases each year, as scanner equipment and scanning protocols become ever more sensitive to subtle abnormalities. Many of these incidental findings are low risk and do not need rigorous imaging follow-up. Researchers therefore suggest revising management guidelines with an eye toward less radiological intervention.
The number of brain MR scans obtained in the clinical and research setting increases each year, as scanner equipment and scanning protocols become ever more sensitive to subtle abnormalities. Many of these incidental findings are low risk and do not need rigorous imaging follow-up. Researchers therefore suggest revising management guidelines with an eye toward less radiological intervention.
That conclusion was reached by investigators at Erasmus MC University Medical Center in Rotterdam, the Netherlands, after reviewing the brain scans of 2000 asymptomatic research subjects. They found that 1.6% of subjects had benign primary tumors, mainly meningiomas, classified by typical radiological characteristics such as location, shape, and signal intensity (NEJM 2007; 357[18]:1821-1828). Despite a documented slow growth rate for such asymptomatic tumors, current practice dictates close clinical and radiological follow-up.
"Such follow-up for all persons incidentally found to have meningiomas would be performed in otherwise healthy asymptomatic persons, at a considerable financial and psychological cost," senior author Dr. Aad van der Lugt told Diagnostic Imaging.
The group also found a 1.8% incidence of cerebral aneurysms, all but two located in the anterior circulation, and most smaller than 7 mm. The reported risk for such findings is zero over four years. Van de Lugt and colleagues suggested that preventive surgery or treatment is not indicated and noted that the benefit of longer follow-up is not yet proven.
The prevalence of meningiomas and small aneurysms in this study was much higher than previously reported. Van der Lugt credits the scanning protocol, especially the high-resolution proton density-weighted sequence, which permitted excellent visualization of the circle of Willis compared with conventional T1- and T2-weighted sequences.
Artifact Reduction Drives Technology Advances with Updated Version of Echelon Synergy MRI System
October 30th 2024Emerging technologies included with the 10th version of the 1.5T MRI platform include Synergy DLR Clear and Synergy Vision that are geared toward mitigating common challenges with artifacts.
FDA Expands Clearance of MRI-Guided AI Platform for Deep Brain Stimulation and Lesioning Techniques
September 3rd 2024Utilizing a new machine learning model, the OptimMRI software may improve radiosurgery applications and lesioning techniques such as MRI-guided focused ultrasound through enhanced targeting of the inferolateral part of the ventral intermediate nucleus (VIM).